about
Cancer metabolism as a central driving force of glioma pathogenesisQuantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique.Metabolic Reprogramming in Brain Cancer: A Coordinated Effort.Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@ast
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@en
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@nl
type
label
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@ast
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@en
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@nl
prefLabel
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@ast
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@en
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@nl
P2860
P356
P1433
P1476
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
@en
P2093
Daniel R. Wahl
Sriram Venneti
P2860
P356
10.1111/BPA.12309
P407
P577
2015-11-01T00:00:00Z